Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Zolgensma First To Be Subject To New German Data Collection Rules
Price & Reimbursement Body Sets Out New Process
Aug 18 2020
•
By
Francesca Bruce
Zolgensma Is The First Drug To Be Affected By Germany's New Data Generation Rules
More from Cell & Gene Therapies
More from Advanced Technologies